Skip to main content

Neurology Clinical Trials

Our neurology clinical trials are dedicated to advancing treatments for a wide range of neurological conditions through carefully conducted clinical studies.

Expanding Possibilities in Neurology Care

Our strongest therapeutic focus is Alzheimer’s disease, where we aim to explore new treatment possibilities that may improve patient outcomes and quality of life. Dr. Rinaldo Caro Sanchez serves as the Director of the Alzheimer’s Disease Program, guiding research efforts with expertise and compassion.

As a member of the Alzheimer’s Clinical Trial Consortium (ACTC), our site participates in studies that bring access to potential new therapies and the latest advancements in Alzheimer’s research. Patients involved in our trials receive close medical oversight and ongoing support throughout their participation.

Join the Effort to Improve Alzheimer’s Care

This clinical trial is evaluating an investigational treatment for people with early Alzheimer’s Disease. It aims to assess the safety and effectiveness of a study drug in individuals with early AD.

Participants receive regular medical oversight, supportive care, and check-ins throughout the study. By taking part, individuals contribute to research that could shape future treatment options and help improve care for patients facing similar challenges.

Age

55 Years to 90 Years

Condition

Early Alzheimer’s Disease

Gender

Both

Status

Active

Enroll Now
early azheimer's disease clinical trial
Clinical Trials for Agitation in Dementia

A Potential New Approach to Manage Agitation in Alzheimer’s

This clinical trial explores a potential new treatment for agitation in dementia of the Alzheimer’s type. Participants receive supportive care and close medical oversight while researchers study how the therapy may help ease symptoms and improve daily life.

The study offers continuous support, careful monitoring, and guidance to ensure participants’ well-being throughout the trial.

Age

50 Years to 90 Years

Condition

Alzheimer’s Type Dementia

Gender

Both

Status

Recruiting

Enroll Now

Exploring New Treatment Possibilities for Dementia

This clinical trial is designed to explore a potential new treatment option for managing agitation in dementia. With careful monitoring and compassionate support, the study aims to better understand how an investigational therapy may ease symptoms and improve comfort. By participating, individuals contribute to vital research that could enhance future care for countless patients and families.

Age

40 Years and older

Condition

Dementia

Gender

Both

Status

Recruiting

Enroll Now
dementia clinical trials
FAQ’s

Frequently Asked Questions

Have questions about our neurology clinical trials? Here are some common questions to help you understand the studies better.

Who can participate in a clinical trial?

Eligibility depends on age, condition, and other study-specific criteria. Our team will guide you through the screening process.

What can participants expect during a trial?

Participants receive continuous medical supervision, supportive care, and guidance throughout the study to ensure their well-being.

Are clinical trials safe?

All trials follow strict regulatory guidelines, with ongoing monitoring to prioritize participant safety.

Do participants have to pay for treatments or visits?

Eligible participants typically receive study treatments and related medical evaluations at no cost.